Target Coverage and Dose Criteria Based Evaluation of the First Clinical 1.5T MR-linac SBRT Treatments of Lymph Node Oligometastases Compared With Conventional CBCT-linac Treatment
Radiotherapy and Oncology - Netherlands
doi 10.1016/j.radonc.2020.02.011
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2020
Authors
Publisher
Elsevier BV